Your session is about to expire
← Back to Search
Obstructive sleep apnea testing for Oral Squamous Cell Carcinoma (OSA-HN Trial)
N/A
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects between the ages of 21 (inclusive) and 90 (inclusive). Anyone that is over 89 years old will be labeled as 89 in the data analysis.
Patients with an established relationship with the adult Otolaryngology and/or Radiation Oncology clinic at AMC or HRH.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 weeks
Awards & highlights
OSA-HN Trial Summary
This trial is studying sleep apnea in people with squamous cell carcinoma of the head and neck. They hope to find out more about the disease course, risk factors, and impact on quality of life with treatment.
Eligible Conditions
- Oral Squamous Cell Carcinoma
- Squamous Cell Carcinoma
- Obstructive Sleep Apnea
OSA-HN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOSA-HN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ACE-27 (Adult Comorbidity Evaluation 27)
Chronic Pain Assessment
EORTC-HN35 (European Organization for Research and Treatment of Cancer)
+3 moreOSA-HN Trial Design
1Treatment groups
Experimental Treatment
Group I: Research groupExperimental Treatment1 Intervention
Sleep apnea testing will be performed with this group, in the form of quality of life and sleep questionnaires, home sleep study results, as well as information collected from their electronic medical record. The investigator will also obtain blood laboratory specimens to measure serum TNF-alpha and IL-6.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,726 Previous Clinical Trials
2,141,676 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,613 Previous Clinical Trials
40,918,315 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger